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Abstract
Background: Diet and obesity are recognized in the scientific literature as important risk factors for cancer
development and progression. Hypercholesterolemia facilitates lymphoma lymphoblastic cell growth and in time
turns in hypocholesterolemia that is a sign of tumour progression. The present study examined how and where the
cholesterol acts in cancer cells when you reproduce in vitro an in vivo hypercholesterolemia condition.
Methods: We used non-Hodgkin’s T cell human lymphoblastic lymphoma (SUP-T1 cell line) and we studied cell
morphology, aggressiveness, gene expression for antioxidant proteins, polynucleotide kinase/phosphatase and
actin, cholesterol and sphingomyelin content and finally sphingomyelinase activity in whole cells, nuclei and
nuclear lipid microdomains.
Results: We found that cholesterol changes cancer cell morphology with the appearance of protrusions together to
the down expression of β-actin gene and reduction of β-actin protein. The lipid influences SUP-T1 cell aggressiveness
since stimulates DNA and RNA synthesis for cell proliferation and increases raf1 and E-cadherin, molecules involved in
invasion and migration of cancer cells. Cholesterol does not change GRX2 expression but it overexpresses SOD1, SOD2,
CCS, PRDX1, GSR, GSS, CAT and PNKP. We suggest that cholesterol reaches the nucleus and increases the nuclear lipid
microdomains known to act as platform for chromatin anchoring and gene expression.
Conclusion: The results imply that, in hypercholesterolemia conditions, cholesterol reaches the nuclear lipid
microdomains where activates gene expression coding for antioxidant proteins. We propose the cholesterolemia as
useful parameter to monitor in patients with cancer.
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Background
Cholesterol (CHO)-rich diet is now considered an im-
portant risk factor for cancer development [1–3]. How-
ever, although detrimental effect of high level of CHO
for cancer progression have been increasingly noted, we
do not know the mechanisms involved. Llaverias et al.
[4] reported that hypercholesterolemia (hyperCHO), in
association with oncogenic stimuli, leaded to accelerated
tumour formation with subsequent hypocholesterolemia
(hypoCHO). Already Iso et al. [5] had previously shown
that patients with liver cancer often exhibited hypoCHO,
which seemed to be a symptom rather than a cause of
cancer. We demonstrated that severe hypoCHO was a
sign of cancer progression in patients with acute lymphoid
leukemia [6]. In vitro, when serum CHO concentration
was 800 nM corresponding to 280 mg/dl in the blood of
patients, non-Hodgkin’s T cell human lymphoblastic
lymphoma cells (SUP-T1) incorporated CHO with avidity
and used it for their proliferation [6]. Therefore
normal CHO concentration did not influence tumour
growth; otherwise hyperCHO facilitated the entry of
CHO into the cells by stimulating cell growth and
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inducing severe hypoCHO [6]. Recently it has been
highlighted that cell membrane specific lipid microdo-
mains (LMs) rich in CHO and sphingomyelin (SM) or
lipid rafts controlled cancer cell signalling [7, 8]. Cancer
progression involved dysregulation of lipid rafts [9].
Increased CHO content in lipid rafts is associated with
greater survival of prostate cancer cells [10]. After cell
treatment with CHO disrupting or usurping agents, raft-
associated proteins and lipids were dissociated and disease
severity was mitigated [11].
We previously demonstrated the presence of LMs in
the nucleus, in association with inner nuclear membrane
(Nuclear Lipid Microdomains, NLMs), where they acted
as platform for active chromatin anchoring, DNA dupli-
cation and transcription process [12, 13]. CHO-SM rela-
tionship in NLM was different in normal and cancer
cells [14]. Dexamethasone localized in NLM where it
acted as inhibitor of SUP-T1 cell growth [15].
Plasma membrane was supported by an actin network.
The dynamic regulation of actin polymerization into fila-
ments and depolymerization into monomers was the key
for its many functions during cell motility, intracellular
transport and cell shape maintenance [16]. Regulation of
the actin cytoskeleton was imperative to normal cell
function. Tumour invasion and metastasis were increas-
ingly being associated with deregulation of the actin
system [17]. In the diffuse large B-cell lymphoma a β-
actin mutation was identified [18].
Despite the anticancer role of antioxidant enzymes has
been widely demonstrated, proliferation, invasiveness,
migration, apoptosis and drug resistance of cancer have
been associated with the over-expression of antioxidant
enzymes [19]. Superoxide dismutases (SODs) are a fam-
ily of enzymes responsible for the detoxification of ROS;
copper-zinc SOD1 is the predominant dismutase in the
cytoplasm whereas manganese SOD2 is located in the
mitocondria and SOD3 is extracellular [20]. The associ-
ation with the copper chaperone for SOD (CCS) delivers
Cu to SOD1, forms disulfide bond and induces activa-
tion of copper/zinc SOD1 [21]. Glutathione (GSH) is
one of the main antioxidants. The oxidized form of GSH
(GSSG) is reduced back to GSH by the NADPH-
dependent catalysis of the flavoenzyme GSH reductase
(GSR); the novo GSH biosynthesis requires glutathione
synthase (GSS) enzyme [22]. Peroxiredoxins (PRDXs)
are a family of non-selenium-dependent glutathione per-
oxidases which destroy peroxides, organic hydroperox-
ides and peroxynitrite [23]. Glutaredoxins (GRX), also
known as thioltransferases, are a family of glutathione-
dependent thiol oxidoreductase enzymes important in
the maintenance of thiol redox state; they catalyze the
removal of GSH from proteins with a disulfide bridge;
GRX2 is an isoform presents in mitochondria and nuclei
[24]. Catalase (CAT) is primarily an intracellular enzyme
that induces the decomposition of hydrogen peroxide to
water and oxygen. Polynucleotide kinase/phosphatase
(PNKP) is an enzyme involved in the repair of DNA
strand breaks, including base excision repair, single and
double-strand break repair. It possesses 3′-DNA phos-
phatase and 5′-DNA kinase activities useful to restore
the strand structure and consequently to permit the
action of DNA polymerases and ligases [25].
We aimed to test the hypothesis that hyperCHO might
have an important role in the regulation of NLM by
influencing consequently the transcription of genes for
antioxidant proteins useful for the vitality, growth and
aggressiveness of lymphoblastic lymphoma cells.
Results
How the high level of cholesterol influences
lymphoblastic lymphoma cells
We have previously demonstrated that by enriching the
culture medium with 800 nM CHO you reached a level
of CHO corresponding to hyperCHO (280 mg/dl in the
blood of patients). Therefore we used 800nM CHO to
test the effect of hyperCHO on SUP-T1 cells.
First we investigated the possible changes of cell
morphology (Fig. 1). Hematoxylin-eosin staining of con-
trol cells showed round cells with very big nuclei in-
tensely colored occupying almost the whole cell, as
previously shown [26]. No significant differences were in
the major and minor axis (4.37 μm± 0.25); cell surface
area was 19.96 ± 1.75 μm2. Experimental cells changed
the shape, the major axis was 5.25 μm± 1.07 and the
minor axis was 3.91 μm± 1.10; however cell surface area
was similar to that of control sample (21.33 ± 1.30 μm2).
Cellular protrusions were evident (Fig. 1). The expres-
sion fold of β-actin gene expression in Ex sample respect
to C sample was 0.7888 ± 0.056, by indicating a gene
down-regulation. The immunoblotting analysis of β-
actin showed the presence of the band protein in C cells
corresponding to 43 kDa apparent molecular weight
(Fig. 2a); in Ex cells the band was reduced 2.62 times
(Fig. 2b). To investigate if the high CHO levels can
increase cancer cell malignancy, such as proliferation,
migration and/or invasion, we analyzed first DNA and
RNA synthesis after 48 h of cell culture. The results
showed that 800nM CHO stimulated 1.68 times DNA
synthesis and 1.63 times RNA synthesis (Fig. 3), by
indicating that CHO influenced cell proliferation and
activity. Then, we analyzed the behavior of raf1 and e-
cadherin, as molecules involved in migration and/or
invasion of cancer cell [27, 28]. The Fig. 4a showed that
the band corresponding to 69 kDa apparent molecular
weight, highlighted by anti-raf antibody, was increased
after CHO treatment. The band area density analysis
demonstrated that the value of raf1 was higher 1.59
times in Ex sample (Fig. 4b). High levels of CHO
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stimulated strongly e-cadherin (Fig. 4a) whose value in-
creased 5.26 times as shown in Fig. 5, where the gene
expression is referred to that of C cells. CHO treatment
did not change GRX2 expression, overexpressed PRDX1
1.3 times, SOD1 and SOD2 about 1.5 times, GSR-GSS-
CAT between 2.0 and 2.52 times, CCS 3.06 times and
PNKP 3.75 times.
HyperCHO influences nuclear lipid microdomains
Since we previously demonstrated the role of the SUP-
T1 NLM in transcription process [15], we tested the
possibility that the culture medium hyperCHO could
influence NLM composition and function. The level of
N and NLM purification was similar to that previously
reported [12, 15, 29]. In the Ex cells. the levels of protein
and DNA expressed as μg/106 cells did not change in
cell, N and NLM in comparison with C samples; the
level of RNA increased 1.31 times only in NLM. The
level of CHO increased 1.59, 1.52, 1.78 in cell, N and
NLM, respectively; the level of SM increased 1.94, 1.37,
1.90 in cell, N and NLM, respectively (Fig. 6a). If you
express the data of NLM as μg/mg protein you can see
that only CHO and SM changed (Fig. 6b). The SMase
activity was inhibited 1.94 times in cells, 1.37 times in N
and 1.90 times in NLM. (Fig. 7). By expressing the data
as percentage of activity respect to the control samples,
it was evident that the activity in cells and in NLM was
more inhibited than in N (Fig. 7).
Discussion
The main finding of this study is that by reproducing in
vitro a condition of in vivo hyperCHO, lymphoma
lymphoblastic cells overexpressed genes for antioxidant
proteins (SOD1, SOD2, CCS, GSR, GSS and CAT) with
the only exception of GRX2. These proteins counteract
the oxidative stress that induces damage of lipids, nu-
cleic acids and proteins, by altering their functions. It
has been demonstrated that SOD2 polymorphism was
associated with prostate cancer risk [30]. The sequestra-
tion of GSR by tumour cells yielded them less suscep-
tible to oxidative stress, conferring a selective growth
advantage in tumour cells [31]. The overexpression of
GSS was in human colorectal cancer cell lines and
tissues compared with normal samples [32]. PRDX1 was
identified as a tumor-associated antigen in esophageal
squamous cell carcinoma [33] and acted via mTOR/
p70S6K pathway [34]; its overexpression was demon-
strated in multiple myeloma [35], was associated with
tumour angiogenesis and progression in human hepa-
tocellular cancer [36], provided resistance to docetaxel
treatment of lung cancer [37] and to alkylating agent
Fig. 1 SUP-T1 morfology. The cells were cultured without (control) or with 800nM CHO (experimental) for three days, then they were treated as
reported in Materials and Methods section
Fig. 2 Effect of cholesterol on β-actin protein. Immunoblot of proteins
was probed with anti-β-actin and visualized by ECL after 24 h of culture
without (control) or with 800nM CHO (experimental). Apparent molecular
weight (43 kDa) was calculated according to the migration of molecular
size standards. The area density was calculated with Scion Image
programme on densitometry scanning; the data represent the mean ±
S.D. of three experiments performed in duplicate. (Significance, *P< 0.001
versus Control sample)
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bis-chloroethyl nitroso urea of oligodendroglial tu-
mors [38]. Increased CAT levels were found in pa-
tients with non-small cell lung cancer compared to
controls [39, 40].
We also showed that PNKP, as enzyme involved in
the repair of DNA strand breaks was overexpressed
after CHO incubation, by indicating that the cells
were protected from the damage. On the other hand
it was demonstrated that small inhibitors of PNKP
increased the response to radiations of human lung
carcinoma cells [41].
Therefore we reported the first observation in litera-
ture showing the CHO-antioxidant proteins- PNKP rela-
tionship in cancer. The results obtained might explain
why the hyperCHO stimulated key proteins involved in
cell cycle and survival (RNA polymerase II, STAT3,
PKCzeta, PPARgamma and Cyclin D) and decreased Bax
protein in SUP-T1 cells [6]. Here we showed that
hyperCHO induced changes in cell shape with the
appearance of protrusions that were notably associated
with invasiveness and metastasis [40]. It was shown that
tumour cell migration and invasion required actin cyto-
skeletal reorganization [42]; in addition, β-actin muta-
tion was found in B-cell lymphoma [18]. Our results
highlighted that the β-actin gene was downregulated and
β-actin protein was reduced. The possibility that the β-
actin was mutated also in our experimental model and
therefore it was underestimated should be considered. In
any case a change of β-actin might be responsible for the
morphological modification of the cells. We have shown a
correlation between hyperCHO and increase of DNA and
RNA synthesis as well as raf1 and e-cadherin content,
important molecules for cancer progression [27, 28]. The
results obtained up to this point induced us to investigate
about the possible mechanism of action of CHO in the
regulation of gene expression. We previously demon-
strated that CHO present in inner nuclear membrane
linked SM to form NLM that acted as platform for active
chromatin anchoring and gene expression [12, 13, 15]. So
we wondered if the CHO, incorporated into the cells,
might reach NLM by influencing their composition and,
as a result, their function. Thus we demonstrated that
hyperCHO is responsible for the enrichment of CHO
in NLM and for the inhibition of SMase activity. In
intranuclear environment existed two CHO-SM pools
Fig. 3 Effect of cholesterol on DNA and RNA synthesis. DNA synthesis was studied by evaluating the incorporation of 3H-thymidine in the DNA
and RNA synthesis by evaluating the incorporation of 3H-UTP in the RNA. The specific activity was calculated as cpm/μg DNA and cpm/μg RNA,
respectively. The data represent the mean ± S.D. of three experiments performed in duplicate. (Significance, *P < 0.001 versus Control sample)
Fig. 4 Effect of cholesterol on raf1 and e-cadherin proteins. a
Immunoblot of proteins was probed with specific antibodies
and visualized by ECL after 24 h of culture without (control)
or with 800nM CHO (experimental). Apparent molecular weights
were calculated according to the migration of molecular size standards;
b The area density was calculated with Scion Image programme on
densitometry scanning; the data represent the mean ± S.D. of three
experiments performed in duplicate. (Significance, *P < 0.001 versus
Control sample)
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regulated by SMase, CHO-SM linked pool and CHO-
SM free pool [43, 44]. The intranuclear CHO-SM
linked pool was that present in NLM [12]. CHO, in
turn, was able to regulate SMase [43, 44]. Thus it
was possible to hypothesise that CHO inhibited
SMase to have more SM to link and to enrich the
nucleus of platforms for gene expression.
Conclusion
In conclusion our data showed an association between
hyperCHO and enrichment of NLM in inner nuclear mem-
brane, increase of DNA and RNA synthesis and changes of
antioxidant gene expression. It is possible to suggest that
CHO, by keeping under control the oxidative status of
cancer cells, might allow their vitality and growth.
Fig. 5 Effect of cholesterol on SOD1, SOD2, CCS, GSR, GSS, PRDX1, GRX2, CAT, PNKP expression. RTqPCR analysis was performed in control (without
CHO) and experimental SUP-T1 cells (with 800nM CHO) collected after 24 h of culture. The results were normalized with the levels of the GAPDH and
expressed as mRNA of experimental sample versus control sample. Data are expressed as the mean ± S.D. of 3 independent experiments performed in
three PCR replicates
Fig. 6 SUP-T1 composition. The cells were cultured without (control) or with 800nM CHO (experimental) and collected after 24 h. a cholesterol
(CHO), sphingomyelin (SM), DNA and RNA content in cells, nuclei (N) and nuclear lipid microdomains (NLM), the data are expressed as μg/106
cells and represent the mean ± S.D. of four experiments performed in duplicate; b CHO, SM, DNA and RNA content in NLM, the data are
expressed as μg/mg protein and represent the mean ± S.D. of four experiments performed in duplicate. (Significance, *P < 0.001 versus
Control sample)
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Methods
Materials
Non-Hodgkin’s T cell human lymphoblastic lymphoma
(SUP-T1) were obtained from Biological Materials Bank
(ICLC)-CBA-Genoa. 3H palmytic acid, [3H] thymidine
and [3H] UTP (41 Ci/mmol, 1.52 TBq/mmol) were
obtained from Amersham Pharmacia Biotech (Rainham,
Essex, UK); Ecoscint A was obtained from National
Diagnostic (Atlanta, GA, USA); Thin layer chromatog-
raphy (TLC) plates (silica Gel G60) were from Merck,
Darmstadt, Germany; CHO, SM, Fetal bovine serum
(FBS), RPMI 1640 Medium, PSF (penicillin, strepto-
mycin and fungizone) were purchased from Sigma
Aldrich Co. (St. Louis, MO, USA). Anti-actin, anti-
Raf1, anti-phosphoRaf1 and anti-E-cadherin anti-
bodies were obtained from Santa Cruz Biotechnol-
ogy, Inc. (California, USA).
Cell culture and treatments
SUP-T1 cells were grown as previously reported [6]. For
each experiments, two lots of cells were prepared: the
control sample (C) without CHO and the experimental
sample (Ex) with 800nM CHO. After 24 h of culture,
part of the cells were used for their analysis and part for
Nuclei (N) and Nuclear Membrane Microdomains
(NLM) purification.
Cell morphology
SUP-T1 cells, cultured for three days, were fixed and
submitted to the hematoxylin-eosin staining as previ-
ously reported [26] and analyzed by inverted microscopy
EUROMEX FE 2935 (ED Amhem, The Netherland)
equipped with a CMEX 5000 camera system (40x mag-
nification). The analysis of cell size was performed by
ImageFocus software.
DNA and RNA synthesis
The DNA and RNA synthesis was studied in synchro-
nized cells by using [3H]-thymidine or [3H]-UTP as
precursor, previously reported [44, 45]. After syncroniza-
tion, the cells were cultured for 48 h of in the absence (C)
or presence (Ex) of 800nM CHO; 1 μCi [3H]-thymidine or
1 μCi [3H]-UTP was added to the culture medium 3 h
before the analysis. The data of the radioactivity were
referred to the DNA or RNA amount and expressed as
cpm/μg DNA and cpm/μg RNA, respectively.
Nuclei purification
The nuclei (N) were purified from 20x106 SUP-T1 cells
and checked for possible cytoplasmic contamination as
previously reported [43].
Nuclear Lipid Microdoman purification
The Nuclear Lipid Microdomains (NLMs) were purified
from 1x109 SUP-T1 cells and checked for possible and
nuclear contamination as previously reported [15].
Biochemical determinations
Protein, DNA and RNA contents were determined as
previously reported [43].
Western blotting
About 30 μg of cell proteins were submitted to SDS-
PAGE electrophoresis in 10 % polyacrylamide slab gel.
Proteins were transferred into nitrocellulose for 90 min
as previously described [12]. The membranes were
blocked for 30 min with 0.5 % no-fat dry milk in PBS
(pH 7.5) and incubated overnight at 4 °C with the β-
actin specific antibody. The blots were treated with
HRP-conjugated secondary antibodies for 90 min.
Visualization was performed with the enhanced chemi-
luminescence kit from Amersham (Rainham, Essex, UK).
The apparent molecular weight of β-actin, raf1 and e-
cadherin was calculated according to the migration of
molecular size standards. The area density of the bands
was evaluated by densitometry scanning and analyzed
with Scion Image.
Fig. 7 Sphingomyelinase activity. The cells were cultured without
(control) or with 800nM CHO (experimental) and collected after
24 h; cell, nuclei (N) and nuclear lipid microdomains (NLM) were
prepared as reported in Materials and Methods section. a The data
are expressed as pmol/mg protein/min; b the data are expressed as
percentage respect to control samples. (Significance, *P < 0.001
versus Control sample)
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Lipid analysis
Lipids were extracted and CHO measured, after thin-
layer chromatography (TLC) separation, as previously
reported [46]. To evaluate SM the cells were incubated
with 1 μCi/ml of 3[H] palmitic acid, diluted with cold
palmitic acid as previously reported [15]. After 24 h, the
cells from 5 flasks were pooled and NLM were purified.
The lipids were extracted, separated on TLC and ana-
lysed as reported by Cascianelli et al. [6]. The radioactiv-
ity was measures in counting vials with 10 ml Ecoscint
A and 1 ml water and the radioactivity was measured
with a Packard liquid scintillation analyser (Packard
Instrument Company, Meriden, CT, USA).
Sphingomyelinase activity
The sphingomyelinase (SMase) activity was detected
according to Albi et al. [47]. Incubations were performed
at 37 °C for 45 min. The reaction was stopped by adding
2 ml chloroform and methanol (2:1), 0.4 ml of 0.5 %
NaCl was added to the tubes and vortexed. After centrifu-
gation at 2000 RPM × 10 min, the upper phase was
removed and 0.5 ml was diluted in counting vials with
10 ml Ecoscint A and 1 ml distilled water; radioactivity
was measured with a Packard liquid scintillation analyzer.
Reverse transcription quantitative PCR (RTqPCR)
Control and experimental SUP-T1 cells were used for
total RNA extraction performed by using RNAqueous
®-4PCR kit (Ambion Inc., Austin, Texas), as previously
reported [25]. cDNA was synthesized under the follow-
ing conditions: 50 °C for 2 min, 95 °C for 10 min, 95 °C
for 15 s and 60 °C for 1 min for 40 cycles. RTqPCR was
performed using Master Mix TaqMan®Gene Expression
and 7.300 RT-PCR instrument (Applied Biosystems), target-
ing β-actin (ACTB; Hs99999903), Superoxide dismutase 1
(SOD1; Hs00533490_m1), Superoxide dismutase 2 (SOD2;
Hs00167309_m1), Copper Chaperone for SOD (CCS; Hs00
192851_m1), Glutathione reductase (GSR; Hs00167317_
m1), Glutathione synthase (GSS; Hs00609286_m1), Perox-
iredoxins (PRDXs; Hs00602020_mH), Glutaredoxin2 (GR
X2; Hs00375015_m1), Catalase (CAT; Hs00156308_m1),
Polynucleotide kinase/phosphatase (PNKP; Hs00892544_
m1). The results were normalized with the levels of the
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Hs
02758991_g1) housekeeping gene.
Statistical analysis
Three experiments in duplicate where performed for
each analysis. The data are expressed as mean ± S.D. and
t test was used for statistical analysis.
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